Nucleic Acid Testing Market Size to Hit USD 8.42 Billion by 2035, Growing at a 6.57% CAGR – SNS Insider

▤ Summary

The article projects steady growth in the nucleic acid testing market through 2035, driven by rising infection rates, oncology testing demand, precision medicine adoption, and rapid molecular diagnostics. It highlights strong usage in hospitals, diagnostic laboratories, and pharmaceutical and biotechnology companies. It also notes that software and services are the fastest-growing segment because of laboratory digitization, AI-powered workflow automation, and molecular data analytics. Recent developments from Thermo Fisher Scientific and Roche Diagnostics point to continued investment in automated workflows, multiplex assays, and integrated digital lab tools.

▦ Linked Companies